|
|
|
Volumn 30, Issue 2, 2005, Pages 152-
|
|
Selective serotonin reuptake inhibitors (SSRIs) and depression after myocardial infarction (MI)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
C REACTIVE PROTEIN;
CARDIAC AGENT;
FLUOXETINE;
LOW DENSITY LIPOPROTEIN;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
STATINE DERIVATIVE;
BODY WEIGHT DISORDER;
CLINICAL TRIAL;
DEPRESSION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
HAMILTON SCALE;
HEART INFARCTION;
HUMAN;
ISCHEMIC HEART DISEASE;
NOTE;
REMISSION;
RISK FACTOR;
SIDE EFFECT;
TREATMENT OUTCOME;
UNSTABLE ANGINA PECTORIS;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
MAJOR DEPRESSION;
PSYCHOLOGICAL ASPECT;
RANDOMIZED CONTROLLED TRIAL;
DEPRESSIVE DISORDER, MAJOR;
HUMANS;
MYOCARDIAL INFARCTION;
RANDOMIZED CONTROLLED TRIALS;
SEROTONIN UPTAKE INHIBITORS;
SERTRALINE;
|
|
EID: 20044393718
PISSN: 11804882
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
